Prosight Management »

Mural Oncology shares owned by Prosight Management

Quarter-by-quarter ownership of Mural Oncology (MURA) shares owned by Prosight Management from 13F filings

Historical chart of Prosight Management investment in Mural Oncology

Tip: Access up to 7 years of quarterly data

All positions including Mural Oncology held by Prosight Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mural Oncology by Prosight Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.0M 400k 4.89

More positions owned by Prosight Management

Shattuck Labs (STTK)
Adc Therapeutics Sa SHS (ADCT)
Galapagos Nv Spon Adr (GLPG)
Meiragtx Holdings (MGTX)
Kura Oncology (KURA)
Roivant Sciences SHS (ROIV)
Bridgebio Pharma (BBIO)
Cytokinetics Com New (CYTK)
Medtronic SHS (MDT)
Orthopediatrics Corp. (KIDS)
Mirum Pharmaceuticals (MIRM)
Guardant Health (GH)
Kelly Svcs Cl A (KELYA)
Abcellera Biologics (ABCL)
Erasca (ERAS)

View all positions for Prosight Management

Top funds holding Mural Oncology

Armistice Capital
Westfield Capital Management Company
BlackRock
Vanguard Group
Verition Fund Management
Solas Capital Management
Alta Fundamental Advisers
Newtyn Management
Prosight Management
Geode Capital Management
PRIMECAP Management Company
Baker Bros. Advisors
Sonic GP
Nuveen Asset Management
Squarepoint Ops

View all funds holding Mural Oncology